GSK_Annual_Report_2021

Notes to the Consolidated Financial Statements for the year ended March 31, 2021 (contd.) Annual Report 2020-21 191 ( ` in lakhs) As at March 31, 2021 As at March 31, 2020 Note12 : Bankbalancesotherthancashandcashequivalents Earmarked Balances: Unclaimed dividend accounts 19,86.36 20,44.34 Term deposits with original maturity period of more than three months but less than twelve months 732,01.45 957,01.45 Margin money 91.12 93.39 752,78.93 978,39.18 Note 13 : Current financial assets - Others (Unsecured considered good) Receivable from group companies 17,89.12 7,39.26 Interest accrued on deposits with banks 7,50.83 23,22.20 Advances recoverable 31.65 44.62 25,71.60 31,06.08 Note 14 : Other current assets Balances with Government Authorities 46,34.50 43,23.64 Advance to Creditors 9,82.18 15,43.00 Sundry advances 1,15.33 1,15.33 Prepayments and Prepaid Expenses 13,49.57 11,78.88 Others 5,72.29 6,06.31 76,53.87 77,67.16 Note 15 : Assets classified as held for sale Freehold Land and Building 9.60 9.60 Plant and Machinery (Refer Note (a) below) 1.63 1.63 Assets at Vemgal location (Refer Note (b) below) 180,00.61 - 180,11.84 11.23 Notes:- (a) The amount includes Plant and Machinery from Mysore and Bangalore site held for sale. (b) Assets at Vemgal location held for sale consequent to the binding sale agreement entered into by the Group.